From $25B to $55B: Moderna’s Melanoma Math
The Phase 3 win validated the platform. Now the harder work begins: manufacturing every dose from scratch.
Three Stocks for a World Ditching the Dollar
August 25, 2026 De-dollarization is accelerating faster than the calendar suggests. The dollar’s reserve share...
UP-NS Decision Pushed to H2 2027
STB calendar extends arb risk into 2027, with Nov. 18 as the first must-watch date.
Who Absorbs the 15%: Hyperscalers, Margins, or Build Plans?
Nvidia’s memory cost pass-through forces a committee to weigh gross-margin dollars vs. percentage, and deployment vs. delay.
Micron’s CEO Just Called Time on the Boom-Bust Clock
August 25, 2026 A $10 billion research lab, a 50% supply shortfall Micron’s CEO Just...
DAP at $795, Black Sea Shut: Where Fertilizer Fits in the New Wheat Trade
India's export reopening and the Black Sea collapse are redirecting grain flows, but the sharpest opportunity sits in the input…
Elon Musk’s Hushed FCC Filing. Sept 25th.
August 24, 2026 Barrick Gold: The Tax-Efficient Way to Play a $4,600 Metal Bonus Content: Barrick...
CRWD Reports Wednesday. The Bar Is Perfection.
At 175x forward earnings and a 9% implied move, CrowdStrike's Q2 is a textbook binary where the strategy matters more…
CRM Reports in Four Days. The Only Number That Matters.
Agentforce ARR grew 205% last quarter. August 26 reveals whether that was a peak or a floor.
Micron’s CEO Just Called Time on the Boom-Bust Clock
A $10 billion research lab, a 50% supply shortfall, and a forward P/E of 6.76 are telling three different parts…